img

Global General Anaesthetic Medication Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global General Anaesthetic Medication Market Research Report 2024

General anesthetics are drugs that have the ability to bring about a reversible loss of consciousness. Anesthetists administer these drugs to induce or maintain general anaesthesia to facilitate surgery. Some of these drugs are also used in lower dosages for pain management. General anesthesia is used in various cardiac surgeries, hip and knee replacement surgeries, cancer surgeries, and gastro-intestinal surgeries.
According to Mr Accuracy reports’s new survey, global General Anaesthetic Medication market is projected to reach US$ 4983.4 million in 2029, increasing from US$ 3926 million in 2022, with the CAGR of 3.5% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole General Anaesthetic Medication market research.
The general anesthetic for surgery market is primarily driven by the increasing number of surgical procedures performed globally and the growing demand for safe and effective anesthesia to ensure patient comfort and successful surgical outcomes. General anesthesia plays a crucial role in inducing a reversible state of unconsciousness and analgesia during surgery, allowing surgeons to perform complex procedures with minimal patient discomfort. Moreover, advancements in anesthesia delivery systems and monitoring technologies contribute to the market's growth by enhancing anesthesia administration precision and patient safety. However, the market also faces challenges, including the potential for adverse reactions and complications associated with general anesthesia, such as postoperative nausea and vomiting (PONV) or rare anesthetic-related reactions. Ensuring patient safety and minimizing the risk of adverse events remain key challenges for healthcare providers and anesthesiologists. Additionally, the availability and accessibility of anesthesia services in remote or underserved regions can be limited, hindering access to surgical care for some patients.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global General Anaesthetic Medication market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Aspen Pharma
Fresenius-Kabi
AbbVie
Baxter Healthcare
B.Braun
Maruishi
Piramal
Hikma Pharmaceuticals
Yichang Humanwell
Nhwa
Hengrui
Xi'an Libang
Segment by Type
Propofol
Sevoflurane
Remifentanil
Etomidate
Isoflurane
Other

Segment by Application


Intravenous Anesthetics
Inhalational Anesthetics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The General Anaesthetic Medication report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global General Anaesthetic Medication Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Propofol
1.2.3 Sevoflurane
1.2.4 Remifentanil
1.2.5 Etomidate
1.2.6 Isoflurane
1.2.7 Other
1.3 Market by Application
1.3.1 Global General Anaesthetic Medication Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Intravenous Anesthetics
1.3.3 Inhalational Anesthetics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global General Anaesthetic Medication Market Perspective (2018-2029)
2.2 General Anaesthetic Medication Growth Trends by Region
2.2.1 Global General Anaesthetic Medication Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 General Anaesthetic Medication Historic Market Size by Region (2018-2024)
2.2.3 General Anaesthetic Medication Forecasted Market Size by Region (2024-2029)
2.3 General Anaesthetic Medication Market Dynamics
2.3.1 General Anaesthetic Medication Industry Trends
2.3.2 General Anaesthetic Medication Market Drivers
2.3.3 General Anaesthetic Medication Market Challenges
2.3.4 General Anaesthetic Medication Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top General Anaesthetic Medication Players by Revenue
3.1.1 Global Top General Anaesthetic Medication Players by Revenue (2018-2024)
3.1.2 Global General Anaesthetic Medication Revenue Market Share by Players (2018-2024)
3.2 Global General Anaesthetic Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by General Anaesthetic Medication Revenue
3.4 Global General Anaesthetic Medication Market Concentration Ratio
3.4.1 Global General Anaesthetic Medication Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by General Anaesthetic Medication Revenue in 2022
3.5 General Anaesthetic Medication Key Players Head office and Area Served
3.6 Key Players General Anaesthetic Medication Product Solution and Service
3.7 Date of Enter into General Anaesthetic Medication Market
3.8 Mergers & Acquisitions, Expansion Plans
4 General Anaesthetic Medication Breakdown Data by Type
4.1 Global General Anaesthetic Medication Historic Market Size by Type (2018-2024)
4.2 Global General Anaesthetic Medication Forecasted Market Size by Type (2024-2029)
5 General Anaesthetic Medication Breakdown Data by Application
5.1 Global General Anaesthetic Medication Historic Market Size by Application (2018-2024)
5.2 Global General Anaesthetic Medication Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America General Anaesthetic Medication Market Size (2018-2029)
6.2 North America General Anaesthetic Medication Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America General Anaesthetic Medication Market Size by Country (2018-2024)
6.4 North America General Anaesthetic Medication Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe General Anaesthetic Medication Market Size (2018-2029)
7.2 Europe General Anaesthetic Medication Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe General Anaesthetic Medication Market Size by Country (2018-2024)
7.4 Europe General Anaesthetic Medication Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific General Anaesthetic Medication Market Size (2018-2029)
8.2 Asia-Pacific General Anaesthetic Medication Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific General Anaesthetic Medication Market Size by Region (2018-2024)
8.4 Asia-Pacific General Anaesthetic Medication Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America General Anaesthetic Medication Market Size (2018-2029)
9.2 Latin America General Anaesthetic Medication Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America General Anaesthetic Medication Market Size by Country (2018-2024)
9.4 Latin America General Anaesthetic Medication Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa General Anaesthetic Medication Market Size (2018-2029)
10.2 Middle East & Africa General Anaesthetic Medication Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa General Anaesthetic Medication Market Size by Country (2018-2024)
10.4 Middle East & Africa General Anaesthetic Medication Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Aspen Pharma
11.1.1 Aspen Pharma Company Detail
11.1.2 Aspen Pharma Business Overview
11.1.3 Aspen Pharma General Anaesthetic Medication Introduction
11.1.4 Aspen Pharma Revenue in General Anaesthetic Medication Business (2018-2024)
11.1.5 Aspen Pharma Recent Development
11.2 Fresenius-Kabi
11.2.1 Fresenius-Kabi Company Detail
11.2.2 Fresenius-Kabi Business Overview
11.2.3 Fresenius-Kabi General Anaesthetic Medication Introduction
11.2.4 Fresenius-Kabi Revenue in General Anaesthetic Medication Business (2018-2024)
11.2.5 Fresenius-Kabi Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Detail
11.3.2 AbbVie Business Overview
11.3.3 AbbVie General Anaesthetic Medication Introduction
11.3.4 AbbVie Revenue in General Anaesthetic Medication Business (2018-2024)
11.3.5 AbbVie Recent Development
11.4 Baxter Healthcare
11.4.1 Baxter Healthcare Company Detail
11.4.2 Baxter Healthcare Business Overview
11.4.3 Baxter Healthcare General Anaesthetic Medication Introduction
11.4.4 Baxter Healthcare Revenue in General Anaesthetic Medication Business (2018-2024)
11.4.5 Baxter Healthcare Recent Development
11.5 B.Braun
11.5.1 B.Braun Company Detail
11.5.2 B.Braun Business Overview
11.5.3 B.Braun General Anaesthetic Medication Introduction
11.5.4 B.Braun Revenue in General Anaesthetic Medication Business (2018-2024)
11.5.5 B.Braun Recent Development
11.6 Maruishi
11.6.1 Maruishi Company Detail
11.6.2 Maruishi Business Overview
11.6.3 Maruishi General Anaesthetic Medication Introduction
11.6.4 Maruishi Revenue in General Anaesthetic Medication Business (2018-2024)
11.6.5 Maruishi Recent Development
11.7 Piramal
11.7.1 Piramal Company Detail
11.7.2 Piramal Business Overview
11.7.3 Piramal General Anaesthetic Medication Introduction
11.7.4 Piramal Revenue in General Anaesthetic Medication Business (2018-2024)
11.7.5 Piramal Recent Development
11.8 Hikma Pharmaceuticals
11.8.1 Hikma Pharmaceuticals Company Detail
11.8.2 Hikma Pharmaceuticals Business Overview
11.8.3 Hikma Pharmaceuticals General Anaesthetic Medication Introduction
11.8.4 Hikma Pharmaceuticals Revenue in General Anaesthetic Medication Business (2018-2024)
11.8.5 Hikma Pharmaceuticals Recent Development
11.9 Yichang Humanwell
11.9.1 Yichang Humanwell Company Detail
11.9.2 Yichang Humanwell Business Overview
11.9.3 Yichang Humanwell General Anaesthetic Medication Introduction
11.9.4 Yichang Humanwell Revenue in General Anaesthetic Medication Business (2018-2024)
11.9.5 Yichang Humanwell Recent Development
11.10 Nhwa
11.10.1 Nhwa Company Detail
11.10.2 Nhwa Business Overview
11.10.3 Nhwa General Anaesthetic Medication Introduction
11.10.4 Nhwa Revenue in General Anaesthetic Medication Business (2018-2024)
11.10.5 Nhwa Recent Development
11.11 Hengrui
11.11.1 Hengrui Company Detail
11.11.2 Hengrui Business Overview
11.11.3 Hengrui General Anaesthetic Medication Introduction
11.11.4 Hengrui Revenue in General Anaesthetic Medication Business (2018-2024)
11.11.5 Hengrui Recent Development
11.12 Xi'an Libang
11.12.1 Xi'an Libang Company Detail
11.12.2 Xi'an Libang Business Overview
11.12.3 Xi'an Libang General Anaesthetic Medication Introduction
11.12.4 Xi'an Libang Revenue in General Anaesthetic Medication Business (2018-2024)
11.12.5 Xi'an Libang Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global General Anaesthetic Medication Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Propofol
Table 3. Key Players of Sevoflurane
Table 4. Key Players of Remifentanil
Table 5. Key Players of Etomidate
Table 6. Key Players of Isoflurane
Table 7. Key Players of Other
Table 8. Global General Anaesthetic Medication Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global General Anaesthetic Medication Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 10. Global General Anaesthetic Medication Market Size by Region (2018-2024) & (US$ Million)
Table 11. Global General Anaesthetic Medication Market Share by Region (2018-2024)
Table 12. Global General Anaesthetic Medication Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 13. Global General Anaesthetic Medication Market Share by Region (2024-2029)
Table 14. General Anaesthetic Medication Market Trends
Table 15. General Anaesthetic Medication Market Drivers
Table 16. General Anaesthetic Medication Market Challenges
Table 17. General Anaesthetic Medication Market Restraints
Table 18. Global General Anaesthetic Medication Revenue by Players (2018-2024) & (US$ Million)
Table 19. Global General Anaesthetic Medication Market Share by Players (2018-2024)
Table 20. Global Top General Anaesthetic Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in General Anaesthetic Medication as of 2022)
Table 21. Ranking of Global Top General Anaesthetic Medication Companies by Revenue (US$ Million) in 2022
Table 22. Global 5 Largest Players Market Share by General Anaesthetic Medication Revenue (CR5 and HHI) & (2018-2024)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players General Anaesthetic Medication Product Solution and Service
Table 25. Date of Enter into General Anaesthetic Medication Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global General Anaesthetic Medication Market Size by Type (2018-2024) & (US$ Million)
Table 28. Global General Anaesthetic Medication Revenue Market Share by Type (2018-2024)
Table 29. Global General Anaesthetic Medication Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 30. Global General Anaesthetic Medication Revenue Market Share by Type (2024-2029)
Table 31. Global General Anaesthetic Medication Market Size by Application (2018-2024) & (US$ Million)
Table 32. Global General Anaesthetic Medication Revenue Market Share by Application (2018-2024)
Table 33. Global General Anaesthetic Medication Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 34. Global General Anaesthetic Medication Revenue Market Share by Application (2024-2029)
Table 35. North America General Anaesthetic Medication Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America General Anaesthetic Medication Market Size by Country (2018-2024) & (US$ Million)
Table 37. North America General Anaesthetic Medication Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe General Anaesthetic Medication Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 39. Europe General Anaesthetic Medication Market Size by Country (2018-2024) & (US$ Million)
Table 40. Europe General Anaesthetic Medication Market Size by Country (2024-2029) & (US$ Million)
Table 41. Asia-Pacific General Anaesthetic Medication Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 42. Asia-Pacific General Anaesthetic Medication Market Size by Region (2018-2024) & (US$ Million)
Table 43. Asia-Pacific General Anaesthetic Medication Market Size by Region (2024-2029) & (US$ Million)
Table 44. Latin America General Anaesthetic Medication Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Latin America General Anaesthetic Medication Market Size by Country (2018-2024) & (US$ Million)
Table 46. Latin America General Anaesthetic Medication Market Size by Country (2024-2029) & (US$ Million)
Table 47. Middle East & Africa General Anaesthetic Medication Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 48. Middle East & Africa General Anaesthetic Medication Market Size by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa General Anaesthetic Medication Market Size by Country (2024-2029) & (US$ Million)
Table 50. Aspen Pharma Company Detail
Table 51. Aspen Pharma Business Overview
Table 52. Aspen Pharma General Anaesthetic Medication Product
Table 53. Aspen Pharma Revenue in General Anaesthetic Medication Business (2018-2024) & (US$ Million)
Table 54. Aspen Pharma Recent Development
Table 55. Fresenius-Kabi Company Detail
Table 56. Fresenius-Kabi Business Overview
Table 57. Fresenius-Kabi General Anaesthetic Medication Product
Table 58. Fresenius-Kabi Revenue in General Anaesthetic Medication Business (2018-2024) & (US$ Million)
Table 59. Fresenius-Kabi Recent Development
Table 60. AbbVie Company Detail
Table 61. AbbVie Business Overview
Table 62. AbbVie General Anaesthetic Medication Product
Table 63. AbbVie Revenue in General Anaesthetic Medication Business (2018-2024) & (US$ Million)
Table 64. AbbVie Recent Development
Table 65. Baxter Healthcare Company Detail
Table 66. Baxter Healthcare Business Overview
Table 67. Baxter Healthcare General Anaesthetic Medication Product
Table 68. Baxter Healthcare Revenue in General Anaesthetic Medication Business (2018-2024) & (US$ Million)
Table 69. Baxter Healthcare Recent Development
Table 70. B.Braun Company Detail
Table 71. B.Braun Business Overview
Table 72. B.Braun General Anaesthetic Medication Product
Table 73. B.Braun Revenue in General Anaesthetic Medication Business (2018-2024) & (US$ Million)
Table 74. B.Braun Recent Development
Table 75. Maruishi Company Detail
Table 76. Maruishi Business Overview
Table 77. Maruishi General Anaesthetic Medication Product
Table 78. Maruishi Revenue in General Anaesthetic Medication Business (2018-2024) & (US$ Million)
Table 79. Maruishi Recent Development
Table 80. Piramal Company Detail
Table 81. Piramal Business Overview
Table 82. Piramal General Anaesthetic Medication Product
Table 83. Piramal Revenue in General Anaesthetic Medication Business (2018-2024) & (US$ Million)
Table 84. Piramal Recent Development
Table 85. Hikma Pharmaceuticals Company Detail
Table 86. Hikma Pharmaceuticals Business Overview
Table 87. Hikma Pharmaceuticals General Anaesthetic Medication Product
Table 88. Hikma Pharmaceuticals Revenue in General Anaesthetic Medication Business (2018-2024) & (US$ Million)
Table 89. Hikma Pharmaceuticals Recent Development
Table 90. Yichang Humanwell Company Detail
Table 91. Yichang Humanwell Business Overview
Table 92. Yichang Humanwell General Anaesthetic Medication Product
Table 93. Yichang Humanwell Revenue in General Anaesthetic Medication Business (2018-2024) & (US$ Million)
Table 94. Yichang Humanwell Recent Development
Table 95. Nhwa Company Detail
Table 96. Nhwa Business Overview
Table 97. Nhwa General Anaesthetic Medication Product
Table 98. Nhwa Revenue in General Anaesthetic Medication Business (2018-2024) & (US$ Million)
Table 99. Nhwa Recent Development
Table 100. Hengrui Company Detail
Table 101. Hengrui Business Overview
Table 102. Hengrui General Anaesthetic Medication Product
Table 103. Hengrui Revenue in General Anaesthetic Medication Business (2018-2024) & (US$ Million)
Table 104. Hengrui Recent Development
Table 105. Xi'an Libang Company Detail
Table 106. Xi'an Libang Business Overview
Table 107. Xi'an Libang General Anaesthetic Medication Product
Table 108. Xi'an Libang Revenue in General Anaesthetic Medication Business (2018-2024) & (US$ Million)
Table 109. Xi'an Libang Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global General Anaesthetic Medication Market Size Comparison by Type (2024-2029) & (US$ Million)
Figure 2. Global General Anaesthetic Medication Market Share by Type: 2022 VS 2029
Figure 3. Propofol Features
Figure 4. Sevoflurane Features
Figure 5. Remifentanil Features
Figure 6. Etomidate Features
Figure 7. Isoflurane Features
Figure 8. Other Features
Figure 9. Global General Anaesthetic Medication Market Size Comparison by Application (2024-2029) & (US$ Million)
Figure 10. Global General Anaesthetic Medication Market Share by Application: 2022 VS 2029
Figure 11. Intravenous Anesthetics Case Studies
Figure 12. Inhalational Anesthetics Case Studies
Figure 13. General Anaesthetic Medication Report Years Considered
Figure 14. Global General Anaesthetic Medication Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global General Anaesthetic Medication Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global General Anaesthetic Medication Market Share by Region: 2022 VS 2029
Figure 17. Global General Anaesthetic Medication Market Share by Players in 2022
Figure 18. Global Top General Anaesthetic Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in General Anaesthetic Medication as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by General Anaesthetic Medication Revenue in 2022
Figure 20. North America General Anaesthetic Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America General Anaesthetic Medication Market Share by Country (2018-2029)
Figure 22. United States General Anaesthetic Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada General Anaesthetic Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe General Anaesthetic Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe General Anaesthetic Medication Market Share by Country (2018-2029)
Figure 26. Germany General Anaesthetic Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France General Anaesthetic Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. General Anaesthetic Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy General Anaesthetic Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia General Anaesthetic Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries General Anaesthetic Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific General Anaesthetic Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific General Anaesthetic Medication Market Share by Region (2018-2029)
Figure 34. China General Anaesthetic Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Japan General Anaesthetic Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. South Korea General Anaesthetic Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Southeast Asia General Anaesthetic Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. India General Anaesthetic Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Australia General Anaesthetic Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America General Anaesthetic Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America General Anaesthetic Medication Market Share by Country (2018-2029)
Figure 42. Mexico General Anaesthetic Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Brazil General Anaesthetic Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa General Anaesthetic Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa General Anaesthetic Medication Market Share by Country (2018-2029)
Figure 46. Turkey General Anaesthetic Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Saudi Arabia General Anaesthetic Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Aspen Pharma Revenue Growth Rate in General Anaesthetic Medication Business (2018-2024)
Figure 49. Fresenius-Kabi Revenue Growth Rate in General Anaesthetic Medication Business (2018-2024)
Figure 50. AbbVie Revenue Growth Rate in General Anaesthetic Medication Business (2018-2024)
Figure 51. Baxter Healthcare Revenue Growth Rate in General Anaesthetic Medication Business (2018-2024)
Figure 52. B.Braun Revenue Growth Rate in General Anaesthetic Medication Business (2018-2024)
Figure 53. Maruishi Revenue Growth Rate in General Anaesthetic Medication Business (2018-2024)
Figure 54. Piramal Revenue Growth Rate in General Anaesthetic Medication Business (2018-2024)
Figure 55. Hikma Pharmaceuticals Revenue Growth Rate in General Anaesthetic Medication Business (2018-2024)
Figure 56. Yichang Humanwell Revenue Growth Rate in General Anaesthetic Medication Business (2018-2024)
Figure 57. Nhwa Revenue Growth Rate in General Anaesthetic Medication Business (2018-2024)
Figure 58. Hengrui Revenue Growth Rate in General Anaesthetic Medication Business (2018-2024)
Figure 59. Xi'an Libang Revenue Growth Rate in General Anaesthetic Medication Business (2018-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed